Internal R&D spending on medicine in Poland 2018-2022
In 2022, the companies in Poland spent approximately 1.4 billion zloty on research and development in basic medicine and over 1.7 billion zloty in clinical medicine.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Overview
Manufacturing
Trade
Sales
Products & prices
OTC market
R&D and Clinical trials
Pharmacies
Drugstores
Companies
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.